WHO Collaborating Centre for Drug Statistics Methodology

E462928

WHO collaborating centre health statistics organization research organization

The WHO Collaborating Centre for Drug Statistics Methodology is a specialized World Health Organization center responsible for developing and maintaining international standards for drug classification and consumption statistics, including the ATC/DDD system.

Try in SPARQL Jump to: Surface forms Disambiguation Statements Elicitation Referenced by

All labels observed (5)

Label	Occurrences
WHO Collaborating Centre for Drug Statistics Methodology canonical	5
World Health Organization Collaborating Centre for Drug Statistics Methodology	3
ATC/DDD guidelines	1
WHO technical documentation on ATC/DDD system	1
WHOCC for Drug Statistics Methodology	1

How this entity was disambiguated

This entity first appeared as the object of triple T4689705 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.

NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07

Target entity: WHO Collaborating Centre for Drug Statistics Methodology
Context triple: [ATC, maintainedBy, WHO Collaborating Centre for Drug Statistics Methodology]

A. European Monitoring Centre for Drugs and Drug Addiction
The European Monitoring Centre for Drugs and Drug Addiction is an EU agency that provides independent, evidence-based analysis on drugs, drug use, and related consequences to support policymaking in Europe.
B. World Health Organization Model List of Essential Medicines
The World Health Organization Model List of Essential Medicines is a periodically updated catalog of the most effective, safe, and cost-efficient medicines deemed essential for meeting the priority health needs of populations worldwide.
C. Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
The Pharmacovigilance Risk Assessment Committee within the European Medicines Agency is an expert body responsible for evaluating and monitoring the safety of medicines across the European Union and providing recommendations on managing and communicating medicine-related risks.
D. STC on Health, Population and Drug Control
The STC on Health, Population and Drug Control is an African Union specialized technical committee responsible for guiding and coordinating continental policies and programs on public health, population issues, and drug regulation and control.
E. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
F. None of above. chosen
G. Unsure - the case is ambiguous/there is not enough information to decide.

NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07

Target entity: WHO Collaborating Centre for Drug Statistics Methodology
Target entity description: The WHO Collaborating Centre for Drug Statistics Methodology is a specialized World Health Organization center responsible for developing and maintaining international standards for drug classification and consumption statistics, including the ATC/DDD system.

A. European Monitoring Centre for Drugs and Drug Addiction
The European Monitoring Centre for Drugs and Drug Addiction is an EU agency that provides independent, evidence-based analysis on drugs, drug use, and related consequences to support policymaking in Europe.
B. World Health Organization Model List of Essential Medicines
The World Health Organization Model List of Essential Medicines is a periodically updated catalog of the most effective, safe, and cost-efficient medicines deemed essential for meeting the priority health needs of populations worldwide.
C. Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
The Pharmacovigilance Risk Assessment Committee within the European Medicines Agency is an expert body responsible for evaluating and monitoring the safety of medicines across the European Union and providing recommendations on managing and communicating medicine-related risks.
D. STC on Health, Population and Drug Control
The STC on Health, Population and Drug Control is an African Union specialized technical committee responsible for guiding and coordinating continental policies and programs on public health, population issues, and drug regulation and control.
E. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
F. None of above. chosen

Statements (46)

Predicate	Object
instanceOf	WHO collaborating centre ⓘ health statistics organization ⓘ research organization ⓘ
abbreviation	WHOCC DSM ⓘ
affiliatedWith	World Health Organization ⓘ
coordinatesWith	World Health Organization Headquarters ⓘ linked to: World Health Organization national medicines agencies ⓘ pharmaceutical policy makers ⓘ research institutions ⓘ
country	Norway ⓘ
dataUsedBy	health authorities ⓘ international organizations ⓘ researchers ⓘ
develops	international standards for drug classification ⓘ international standards for drug consumption statistics ⓘ
fieldOfWork	drug classification ⓘ drug consumption statistics ⓘ drug utilization research ⓘ health statistics ⓘ pharmaceutical policy ⓘ pharmacoepidemiology ⓘ
focusesOn	comparative drug use studies ⓘ evaluation of pharmaceutical policies ⓘ monitoring trends in drug consumption ⓘ
hasScope	human medicines ⓘ systemic drug classification ⓘ
hostInstitution	Norwegian Institute of Public Health ⓘ
locatedIn	Oslo ⓘ
maintains	ATC classification guidelines ⓘ ATC/DDD Index ⓘ linked to: Anatomical Therapeutic Chemical Classification System DDD assignment principles ⓘ
methodologyName	ATC/DDD methodology ⓘ linked to: Defined Daily Dose system
partOf	WHO network of collaborating centres ⓘ linked to: World Health Organization collaborating institutions network
publishes	ATC/DDD guidelines ⓘ linked to: WHO Collaborating Centre for Drug Statistics Methodology annual updates of ATC/DDD system ⓘ
responsibleFor	Anatomical Therapeutic Chemical classification system ⓘ linked to: Anatomical Therapeutic Chemical Classification System Defined Daily Dose system ⓘ
shortName	WHOCC for Drug Statistics Methodology ⓘ linked to: WHO Collaborating Centre for Drug Statistics Methodology
standardizes	international drug utilization metrics ⓘ measurement of drug consumption ⓘ
subjectOf	WHO technical documentation on ATC/DDD system ⓘ linked to: WHO Collaborating Centre for Drug Statistics Methodology
supports	global comparability of drug use statistics ⓘ international drug utilization research ⓘ rational use of medicines ⓘ
usesLanguage	English ⓘ
website	https://www.whocc.no ⓘ

How these facts were elicited

Referenced by (11)

Full triples — surface form annotated when it differs from this entity's canonical label.

ATC → maintainedBy → WHO Collaborating Centre for Drug Statistics Methodology ⓘ

ATC → updatedBy → WHO Collaborating Centre for Drug Statistics Methodology ⓘ

Anatomical Therapeutic Chemical Classification System → maintainedBy → World Health Organization Collaborating Centre for Drug Statistics Methodology ⓘ